These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7998789)

  • 81. Evidence of linkage between susceptibility to multiple sclerosis and HLA-class II loci in Italian multiplex families.
    Eoli M; Pandolfo M; Amoroso A; Salmaggi A; Zaffaroni M; Gasparini P; DiDonato S; Milanese C; Zeviani M
    Eur J Hum Genet; 1995; 3(5):303-11. PubMed ID: 8556305
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Multiple sclerosis: MHC associations and therapeutic implications.
    Holmes S; Friese MA; Siebold C; Jones EY; Bell J; Fugger L
    Expert Rev Mol Med; 2005 Feb; 7(3):1-17. PubMed ID: 15710050
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Revealing the genetic basis of multiple sclerosis: are we there yet?
    Baranzini SE
    Curr Opin Genet Dev; 2011 Jun; 21(3):317-24. PubMed ID: 21247752
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Immunogenetic heterogeneity of multiple sclerosis in Sardinia.
    Sotgiu S; Pugliatti M; Solinas G; Castiglia P; Sanna A; Rosati G
    Neurol Sci; 2001 Apr; 22(2):167-70. PubMed ID: 11603621
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The genetic and environmental bases of complex human-disease: extending the utility of twin-studies.
    Goodin DS
    PLoS One; 2012; 7(12):e47875. PubMed ID: 23272039
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Genetics of multiple sclerosis.
    Dyment DA; Ebers GC; Sadovnick AD
    Lancet Neurol; 2004 Feb; 3(2):104-10. PubMed ID: 14747002
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The genetics of multiple sclerosis: an up-to-date review.
    Gourraud PA; Harbo HF; Hauser SL; Baranzini SE
    Immunol Rev; 2012 Jul; 248(1):87-103. PubMed ID: 22725956
    [TBL] [Abstract][Full Text] [Related]  

  • 88. TCRBV20S1 polymorphism does not influence the susceptibility to type 1 diabetes and multiple sclerosis in the Sardinian population.
    Fozza C; Zoledzieska M; Pitzalis M; Simula MP; Galleu A; Contini S; Bonfigli S; Cucca F; Longinotti M
    Immunogenetics; 2012 Feb; 64(2):153-4. PubMed ID: 21927869
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Family and population analysis of multiple sclerosis.
    Payami H; Louis EJ; Klitz W; Lo SK; Thomson G
    Genet Epidemiol Suppl; 1986; 1():381-6. PubMed ID: 3471670
    [No Abstract]   [Full Text] [Related]  

  • 90. MS genetics: recent Scandinavian efforts.
    Hillert J
    J Neurovirol; 2000 May; 6 Suppl 2():S15-7. PubMed ID: 10871778
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Bridging the gap from genetic association to functional understanding: the next generation of mouse models of multiple sclerosis.
    Attfield KE; Dendrou CA; Fugger L
    Immunol Rev; 2012 Jul; 248(1):10-22. PubMed ID: 22725951
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Disentangling the molecular mechanisms of multiple sclerosis: The contribution of twin studies.
    Buscarinu MC; Fornasiero A; Ferraldeschi M; Romano S; Reniè R; Morena E; Romano C; Pellicciari G; Landi AC; Fagnani C; Salvetti M; Ristori G
    Neurosci Biobehav Rev; 2020 Apr; 111():194-198. PubMed ID: 31978439
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Genetic factors in multiple sclerosis].
    Cournu-Rebeix I; Lesca G; Tubridy N; Azoulay-Cayla A; Lyon-Caen O; Fontaine B;
    Presse Med; 2001 Dec; 30(37):1844-7. PubMed ID: 11776707
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.
    Moghbeli M
    Cell Mol Neurobiol; 2020 Jan; 40(1):65-85. PubMed ID: 31482432
    [TBL] [Abstract][Full Text] [Related]  

  • 95. From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A.
    Berge T; Leikfoss IS; Harbo HF
    Int J Mol Sci; 2013 Feb; 14(3):4476-97. PubMed ID: 23439554
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Towards a global view of multiple sclerosis genetics.
    Jacobs BM; Peter M; Giovannoni G; Noyce AJ; Morris HR; Dobson R
    Nat Rev Neurol; 2022 Oct; 18(10):613-623. PubMed ID: 36075979
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Multiple sclerosis and human leukocyte antigen genotypes: Focus on the Middle East and North Africa region.
    Maghbooli Z; Sahraian MA; Naser Moghadasi A
    Mult Scler J Exp Transl Clin; 2020; 6(1):2055217319881775. PubMed ID: 31976083
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Ensemble machine learning identifies genetic loci associated with future worsening of disability in people with multiple sclerosis.
    Fuh-Ngwa V; Zhou Y; Melton PE; van der Mei I; Charlesworth JC; Lin X; Zarghami A; Broadley SA; Ponsonby AL; Simpson-Yap S; Lechner-Scott J; Taylor BV
    Sci Rep; 2022 Nov; 12(1):19291. PubMed ID: 36369345
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The genetics of multiple sclerosis: review of current and emerging candidates.
    Muñoz-Culla M; Irizar H; Otaegui D
    Appl Clin Genet; 2013; 6():63-73. PubMed ID: 24019748
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Differences in common heritable blood immune cell populations may underlie MS susceptibility and progression.
    Booth DR; Fewings NL; Parnell GP; McKay FC; Stewart GJ
    Mult Scler J Exp Transl Clin; 2016; 2():2055217316637087. PubMed ID: 28607721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.